| Description | Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting Fibroblast Activating Protein (FAP).Sibrotuzumab is used in the study of colorectal cancer and non-small cell lung cancer. |
| Synonyms | BIBH 1, Anti-Human FAP Recombinant Antibody |
| molecular weight | N/A |
| CAS | 216669-97-5 |
| Storage | store at low temperature | store at -80°C |
| References | 1. Scott AM, et al. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin Cancer Res. 2003 May;9(5):1639-47. |